Madagascar vs Senegal: The number of people with susceptibility test result for rifampicin
Madagascar
4,142
in 2021
Senegal
3,191
in 2021
Madagascar rank
35th
Senegal rank
38th
The number of people with susceptibility test result for rifampicin over time
- Madagascar
- Senegal
How they compare
Madagascar currently reports 4,142 against 3,191 in Senegal, a difference of 951.
That makes Madagascar's figure about 1.3 times Senegal's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Senegal ahead.
Madagascar ranks 35th and Senegal ranks 38th of 155 countries.
Senegal has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Madagascar | Senegal | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2.67 | 2,385 | 2,383 | Senegal |
| 2020s | 2,074 | 2,388 | 314.5 | Senegal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Madagascar or Senegal?
- Madagascar, at 4,142 against 3,191 in Senegal as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Madagascar and Senegal?
- 951, with Madagascar ahead.
- How many years of comparable data are there for Madagascar and Senegal?
- 5 years are reported by both, from 2017 to 2021.
- How do Madagascar and Senegal rank globally for the number of people with susceptibility test result for rifampicin?
- Madagascar ranks 35th and Senegal ranks 38th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.